1. Christo PJ, manchikanti L, Ruan X, et al. Urine drug testing in chronic pain. Pain Physician 2011;14:123-43.
  2. Chou R, Fanciullo GJ, Fine PG et al. Clinical guideline for the use of chronic opioid therapy in chronic noncancer pain. Jour Pain 2009;10(2):113-30.
  3. Gourlay DL, Heit HA, Caplan YH. Urine drug testing in clinical practice. Available at Accessed 25 July 2012.
  4. Moeller KE, Lee KC, Kissack JC. Urine drug screening: a practical guide for clinicians. Mayo Clin Proc 2008;83(7):851.
  5. Reisfield GM, Salazar E, Bertholf RL. Review: rational use and interpretation of urine drug testing in chronic opioid therapy. Ann Clin Lab Sci 2007;37(4):301-14.
  6. Standridge JB, Adams SM, Zotos AP. Urine drug screening: a valuable office procedure. Am Fam Physician 2010;81(5):635-40.
  7. Osborne R, Joel S, trew D, et al. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther 1990;147:12-19.
  8. Bell MD, Murray GR, Mishra P, et al. Buccal morphine-a new route for analgesia. Lance 1985;1:71-3.
  9. Nordberg G, Borg L, Hedner T, et al. CSF and plasma pharmacokinetic s of intramuscular morphine. Eur J Clin Pharmacol 1985;27:677-81.
  10. Oxycontin. Thomson Physicians’ Desk Reference 61st ed. Thomson, Montvale, 2007.
  11. Murray A, Hagen NA. Hydromoprhone. J Pain Symptom Manage 2005;29:s57-s66.
  12. Herring C, Muzyk AJ, Johnston C. Interferences with urine drug screens. J Pharm Pract 2011;24:102-8.